DataKnowledgeCloudtrainingcoordination

COL Q5VT52-1 GLY 000708 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

RPRD2 HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Compound:

N-ACETYL-beta-D-GLUCOSAMINE

Compound (Entity type)

Collection:

human proteoform glycosylation sites oglcnac atlas.csv

File (Entity type)

Description:Information for protein Q5VT52-1 in the context of file GLY_000708

Creation Time:2026-03-02 19:57:26.000000

Results found

Linked to

	Label	Description
	RPRD2 HUMAN Protein (Entity type)	Regulation of nuclear pre-mRNA domain-containing protein 2
	q5vt52-1 400thr 400thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q5vt52-1 399ser 399ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q5vt52-1 991ser 991ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q5vt52-1 396ser 396ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q5vt52-1 422thr 422thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q5vt52-1 547thr 547thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q5vt52-1 501thr 501thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q5vt52-1 554ser 554ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q5vt52-1 568thr 568thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

Protein

RPRD2 HUMAN

Protein (Entity type)

Regulation of nuclear pre-mRNA domain-containing protein 2

Post Translational Modification

q5vt52-1 400thr 400thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q5vt52-1 399ser 399ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q5vt52-1 991ser 991ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q5vt52-1 396ser 396ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q5vt52-1 422thr 422thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q5vt52-1 547thr 547thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q5vt52-1 501thr 501thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q5vt52-1 554ser 554ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q5vt52-1 568thr 568thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.